News

HHS Responds to AAPT's Advocacy for Self-Collected Testing Accessibility

In response to concerns raised about network adequacy and reimbursement standards for self-collected tests, HHS reaffirms its commitment to accessible and affordable healthcare.

AAPT Advocates for Accessible HIV Self-Collection Kits in Letter to FDA

AAPT urges the FDA to support HIV self-collection kits as vital tools for public health innovation and patient-centered care.

AAPT's Response to the Cures 2.0 RFI

Discover AAPT's insights and recommendations for the Cures 2.0 initiative, focusing on advancing innovation and access to patient-centered testing.

AAPT's Recommendations on Enforcement Policies for Emergency Test Use

AAPT provides its perspective on enforcement policies for tests used during emergencies declared under Section 564, advocating for streamlined regulatory approaches.

AAPT's Position on Enforcement Policy for In Vitro Diagnostic Devices

Learn about AAPT's stance on the enforcement policy for certain in vitro diagnostic devices, emphasizing the importance of a swift public health response even in the absence of a formal emergency declaration.

AAPT Launch Announcement

AAPT announces its official launch with founding members Molecular Testing Labs, Previon, and IHD Labs, aiming to drive accessible, patient-centered testing initiatives forward.

AAPT's Response to Senator Cassidy's RFI on Clinical Test Regulation

AAPT's Letter to the U.S. Senate Appropriations Committee

Read AAPT's appeal to the Senate Appropriations Committee, highlighting the need for improved policies and funding for accessible patient-centered testing.